CAPRCapricor Therapeutics, Inc.

$30.40

What is the market doing?

What the tape says about CAPR

Capricor Therapeutics, Inc. is +229% over the past year while the S&P 500 is +23%: 206 points ahead of the market.

+229%

1-year return · S&P 500 +23%

vs 200-day average
−58%

vs 200-day average · a clear downtrend

RSI (14)
75

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
−73%

Below its 52-week high

2024-08-06$3.56 – $35.34 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$30.40
1 monthS&P 500 +3.7%
+3.5%
1 yearS&P 500 +23%
+229%
5 yearsS&P 500 +87%
+501%
vs 50-day average$17.27
−46%
52-week high
$35.34
52-week low
$3.83
Annualised volatility
296%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$1.5M
Calendar-year price return
YearReturn
2026 (year to date)−68%
2025+109%
2024+182%
2023+27%
2022+32%
2021−15%
2020+168%
2019−69%
2018−74%
2017−41%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan107 of 10+15%
Feb106 of 10+2.2%
Mar105 of 10−1.4%
Apr105 of 10+48%
May103 of 10−16%
Jun107 of 10+3.1%
Jul114 of 11+1.2%
Aug116 of 11+4.4%
Sep105 of 10+40%
Oct101 of 10−11%
Nov103 of 10−11%
Dec102 of 10+34%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.